http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0755385-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9baf224a7f84a809ba33ea63af3c9a53 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D273-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D257-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D259-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D255-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D255-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D273-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D259-00 |
| filingDate | 1995-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3deedeb7922bc335b0f705de9b4c3a45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aa7c927a542e25902eec16e2bd3768f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad3b2948087489a2472aa7c668ec0dc0 |
| publicationDate | 1997-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0755385-A1 |
| titleOfInvention | Chelant compounds |
| abstract | The invention provides amphiphilic compounds of the formula (I) Ch-(-L-Ar-(-AH)n)m (where Ch is a hydrophilic chelant moiety or a salt or a chelate thereof); each L is an optionally oxo substituted C2-25-alkylene linker wherein at least one CH2 moiety is replaced by a group X1 (e.g. L may include a chain sequence, an X1(CH2CH2X1)u (where u is a positive integer) such as X1CH2CH2X1, CH2X1CH2CH2X1CH2CH2X1, CH2X1CH2CH2X1CH2CH2X1CH2CH2X1, etc.), and wherein L is optionally interrupted by a metabolizable group M but with the provisos that the terminus of L adjacent Ch is CH¿2? and that the terminus of L adjacent Ar is X?1¿ or a CH¿2? group adjacent or separated by one CH2 from a group X?1¿ (thus, for example the L-Ar linkage may be L?1-X1-Ar, L1-CH¿2-Ar, L1-X1CH2-Ar or L1-X1CH2CH2-Ar, where L1 is the residue of L; each Ar is an aryl ring optionally substituted by or having fused thereto a further aryl ring; each AH is a protic acid group, preferably an oxyacid, e.g. a carbon, sulphur or phosphorus oxyacid or a salt thereof; each X1 is O, S, NR?1 or PR1¿, preferably no more than 3 X1 groups being present in L; each R1 is hydrogen, alkyl or aryl; and m and n are positive integers, m being for example 1 to 4, especially 1 or 2 and n being for example 1, 2 or 3) which are especially suited for use in diagnostic imaging of the hepatobiliary system. |
| priorityDate | 1994-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 184.